| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risk factors for prosthetic joint infection: case-control study.
|
Clin Infect Dis
|
1998
|
3.96
|
|
2
|
Infective endocarditis due to unusual or fastidious microorganisms.
|
Mayo Clin Proc
|
1997
|
2.62
|
|
3
|
Outcome of prosthetic joint infections treated with debridement and retention of components.
|
Clin Infect Dis
|
2006
|
2.53
|
|
4
|
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.
|
JAMA
|
1997
|
2.52
|
|
5
|
Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons.
|
J Infect Dis
|
1995
|
2.37
|
|
6
|
Early and late survival after surgical treatment of culture-positive active endocarditis.
|
Mayo Clin Proc
|
1995
|
2.17
|
|
7
|
Staphylococcus lugdunensis endocarditis: a complication of vasectomy?
|
Mayo Clin Proc
|
1999
|
2.17
|
|
8
|
Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.
|
Clin Infect Dis
|
1997
|
2.04
|
|
9
|
Infective endocarditis caused by HACEK microorganisms.
|
Annu Rev Med
|
1997
|
2.03
|
|
10
|
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.
|
J Clin Microbiol
|
1998
|
2.02
|
|
11
|
DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates.
|
Antimicrob Agents Chemother
|
1998
|
1.79
|
|
12
|
Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience.
|
J Clin Microbiol
|
2000
|
1.65
|
|
13
|
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents.
|
J Infect Dis
|
1996
|
1.63
|
|
14
|
Bacteremia due to Enterococcus avium.
|
Clin Infect Dis
|
1993
|
1.57
|
|
15
|
Xanthomonas maltophilia: an emerging nosocomial pathogen.
|
Mayo Clin Proc
|
1989
|
1.51
|
|
16
|
Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.
|
Clin Infect Dis
|
1996
|
1.46
|
|
17
|
Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial.
|
J Heart Valve Dis
|
1999
|
1.42
|
|
18
|
Follow-up MR imaging in patients with pyogenic spine infections: lack of correlation with clinical features.
|
AJNR Am J Neuroradiol
|
2007
|
1.42
|
|
19
|
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
|
Diagn Microbiol Infect Dis
|
1999
|
1.36
|
|
20
|
Urinary tract infection caused by nontyphoidal Salmonella: report of 30 cases.
|
Urol Int
|
1992
|
1.33
|
|
21
|
Linezolid therapy of Staphylococcus aureus experimental osteomyelitis.
|
Antimicrob Agents Chemother
|
2000
|
1.30
|
|
22
|
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group.
|
Clin Infect Dis
|
1998
|
1.24
|
|
23
|
Ciprofloxacin inhibition of experimental fracture healing.
|
J Bone Joint Surg Am
|
2000
|
1.21
|
|
24
|
In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
|
Diagn Microbiol Infect Dis
|
2000
|
1.19
|
|
25
|
The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster.
|
Antimicrob Agents Chemother
|
2000
|
1.10
|
|
26
|
Quantitative blood cultures in candidemia.
|
Mayo Clin Proc
|
1991
|
1.07
|
|
27
|
Ketolide treatment of Haemophilus influenzae experimental pneumonia.
|
Antimicrob Agents Chemother
|
1999
|
1.06
|
|
28
|
Prosthetic joint infection diagnosed postoperatively by intraoperative culture.
|
Clin Orthop Relat Res
|
2005
|
1.04
|
|
29
|
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.
|
Eur J Clin Microbiol Infect Dis
|
2010
|
1.04
|
|
30
|
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
|
Antimicrob Agents Chemother
|
1992
|
1.04
|
|
31
|
Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty.
|
Mayo Clin Proc
|
1999
|
1.03
|
|
32
|
In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.
|
Diagn Microbiol Infect Dis
|
1998
|
1.03
|
|
33
|
Subarachnoid haemorrhage associated with infectious endocarditis: case report and literature review.
|
Eur J Neurol
|
2002
|
1.01
|
|
34
|
Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature.
|
Am J Orthop (Belle Mead NJ)
|
1998
|
0.98
|
|
35
|
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.
|
Clin Infect Dis
|
1998
|
0.98
|
|
36
|
Mitral stenosis associated with valvular tophi.
|
Mayo Clin Proc
|
1984
|
0.95
|
|
37
|
Infective endocarditis in patients receiving long-term hemodialysis.
|
Mayo Clin Proc
|
2000
|
0.93
|
|
38
|
Candidemia from a urinary tract source: microbiological aspects and clinical significance.
|
Clin Infect Dis
|
1993
|
0.93
|
|
39
|
Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response.
|
Vaccine
|
1999
|
0.92
|
|
40
|
Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
|
Antimicrob Agents Chemother
|
1992
|
0.89
|
|
41
|
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
1994
|
0.89
|
|
42
|
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
|
Eur J Clin Microbiol Infect Dis
|
2005
|
0.89
|
|
43
|
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
|
Antimicrob Agents Chemother
|
1995
|
0.86
|
|
44
|
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
|
Antimicrob Agents Chemother
|
1997
|
0.84
|
|
45
|
DNA sequence resembling vanA and vanB in the vancomycin-resistant biopesticide Bacillus popilliae.
|
J Infect Dis
|
1998
|
0.84
|
|
46
|
The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis.
|
Heart
|
2008
|
0.82
|
|
47
|
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
|
Antimicrob Agents Chemother
|
1990
|
0.82
|
|
48
|
Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
|
Antimicrob Agents Chemother
|
2001
|
0.81
|
|
49
|
Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
|
Antimicrob Agents Chemother
|
2000
|
0.81
|
|
50
|
Clinical aspects of antimicrobial resistance.
|
Mayo Clin Proc
|
2000
|
0.81
|
|
51
|
Werner Forssmann (1904--1979) and his unusual success story.
|
Mayo Clin Proc
|
1979
|
0.80
|
|
52
|
Animal models as predictors of outcome of therapy with broad spectrum cephalosporins.
|
J Antimicrob Chemother
|
1992
|
0.78
|
|
53
|
Serological investigation of enterococcal infections using western blot.
|
Eur J Clin Microbiol Infect Dis
|
1996
|
0.78
|
|
54
|
Cephalosporin antimicrobial agents and related compounds.
|
Mayo Clin Proc
|
1991
|
0.78
|
|
55
|
Otologic involvement in late syphilis.
|
Laryngoscope
|
1984
|
0.78
|
|
56
|
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis.
|
J Infect Dis
|
2000
|
0.77
|
|
57
|
Transesophageal echocardiography and bacterial endocarditis.
|
Circulation
|
1993
|
0.75
|
|
58
|
Infections associated with implantable cardioverter defibrillators--still more questions.
|
Clin Infect Dis
|
1998
|
0.75
|
|
59
|
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
|
Antimicrob Agents Chemother
|
1996
|
0.75
|
|
60
|
Editorial response: Orthopedic prosthesis salvage.
|
Clin Infect Dis
|
1999
|
0.75
|
|
61
|
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
|
Eur J Clin Microbiol Infect Dis
|
2009
|
0.75
|
|
62
|
Werner Forssmann (1904-1979) and his unusual success story.
|
Conn Med
|
1981
|
0.75
|
|
63
|
New developments in infective endocarditis.
|
Curr Opin Cardiol
|
1995
|
0.75
|
|
64
|
69-year-old man with fever, diarrhea, and abdominal pain.
|
Mayo Clin Proc
|
1998
|
0.75
|
|
65
|
Psychosocial care of the cardiac transplant patient: a nursing diagnosis approach.
|
Dimens Crit Care Nurs
|
1990
|
0.75
|
|
66
|
An animal model of pulmonary infection after single lung transplantation.
|
Transplant Proc
|
1996
|
0.75
|
|
67
|
Infectious Diseases Society of America position statement on the role of hospital pharmacists.
|
Clin Infect Dis
|
1998
|
0.75
|
|
68
|
Vertebral osteomyelitis due to Shigella boydii.
|
Clin Infect Dis
|
1996
|
0.75
|
|
69
|
Tularemia with brain abscesses.
|
Neurology
|
2007
|
0.75
|
|
70
|
Infectious rates of central venous pressure catheters: comparison between newly placed catheters and those that have been changed.
|
Mayo Clin Proc
|
1996
|
0.75
|